1,097
Views
1
CrossRef citations to date
0
Altmetric
Coronavirus – Research Article

Inflammatory ocular events after inactivated COVID-19 vaccination

, , , , , & show all
Article: 2138051 | Received 12 Jul 2022, Accepted 16 Oct 2022, Published online: 11 Nov 2022

References

  • Lopez Bernal J, Andrews N, Gower C, Robertson C, Stowe J, Tessier E, Simmons R, Cottrell S, Roberts R, O’Doherty M, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ (Clinical Research Ed). 2021;373(1088). doi:10.1136/bmj.n1088.
  • Tsang HF, Chan LWC, Cho WCS, Yu AC, Yim AK, Chan AK, Ng LP, Wong YK, Pei XM, Li MJ, et al. An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies. Expert Rev Anti Infect Ther. 2021;19(7):1–6. doi:10.1080/14787210.2021.1863146.
  • Vitiello A, Ferrara F, Troiano V, La Porta R. COVID-19 vaccines and decreased transmission of SARS-CoV-2. Inflammopharmacology. 2021;29(5):1357–60. doi:10.1007/s10787-021-00847-2.
  • Bolletta E, Iannetta D, Mastrofilippo V, De Simone L, Gozzi F, Croci S, Bonacini M, Belloni L, Zerbini A, Adani C, et al. Uveitis and other ocular complications following COVID-19 vaccination. J Clin Med. 2021;10(24):5960. doi:10.3390/jcm10245960.
  • Chen X, Wang B, Li X. Acute-onset Vogt-Koyanagi-Harada like uveitis following Covid-19 inactivated virus vaccination. Am J Ophthalmol Case Rep. 2022;26:101404. doi:10.1016/j.ajoc.2022.101404.
  • ElSheikh RH, Haseeb A, Eleiwa TK, Elhusseiny AM. Acute uveitis following COVID-19 vaccination. Ocul Immunol Inflamm. 2021;29(6):1207–09. doi:10.1080/09273948.2021.1962917.
  • Goyal M, Murthy SI, Annum S. Bilateral multifocal choroiditis following COVID-19 vaccination. Ocul Immunol Inflamm. 2021;29(4):753–57. doi:10.1080/09273948.2021.1957123.
  • Mudie LI, Zick JD, Dacey MS, Palestine AG. Panuveitis following vaccination for COVID-19. Ocul Immunol Inflamm. 2021;29(4):741–42. doi:10.1080/09273948.2021.1949478.
  • Pan L, Zhang Y, Cui Y, Wu X. Bilateral uveitis after inoculation with COVID-19 vaccine: a case report. Int J Infect Dis: IJID: Off Publ Int Soc Infect Dis. 2021;113:116–18. doi:10.1016/j.ijid.2021.09.075.
  • Pang K, Pan L, Guo H, Wu X. Case report: associated ocular adverse reactions with inactivated COVID-19 vaccine in China. Front Med. 2021;8:823346. doi:10.3389/fmed.2021.823346.
  • Rabinovitch T, Ben-Arie-Weintrob Y, Hareuveni-Blum T, Shaer B, Vishnevskia-Dai V, Shulman S, Newman H, Biadsy M, Masarwa D, Fischer N, et al. Uveitis After ThE BNT162b2 mRNA vaccination against SARS-CoV-2 Infection: a possible association. Retina (Philadelphia, Pa). 2021;41(12):2462–71. doi:10.1097/IAE.0000000000003277.
  • Chen X, Li X, Li H, Li M, Gong S. Ocular adverse events after inactivated COVID-19 vaccination in Xiamen. Vaccines. 2022;10(3):482. doi:10.3390/vaccines10030482.
  • Pichi F, Aljneibi S, Neri P, Hay S, Dackiw C, Ghazi NG. Association of ocular adverse events with inactivated COVID-19 vaccination in patients in Abu Dhabi. JAMA Ophthalmol. 2021;139(10):1131–35. doi:10.1001/jamaophthalmol.2021.3477.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT . Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–16.
  • Wang MTM, Niederer RL, McGhee CNJ, Danesh-Meyer HV. COVID-19 vaccination and the eye. Am J Ophthalmol. 2022;240:79–98. doi:10.1016/j.ajo.2022.02.011.
  • Cheng JY, Margo CE. Ocular adverse events following vaccination: overview and update. Surv Ophthalmol. 2022;67(2):293–306. doi:10.1016/j.survophthal.2021.04.001.
  • Benage M, Fraunfelder FW. Vaccine-associated uveitis. Mo Med. 2016;113:48–52.
  • World Health O. Causality assessment of an adverse event following immunization (AEFI): user manual for the revised WHO classification 2nd ed edn. Geneva/Switzerland: World Health Organization; 2018.
  • Furer V, Eviatar T, Zisman D, Peleg H, Braun-Moscovici Y, Balbir-Gurman A, Paran D, Levartovsky D, Zisapel M, Elalouf O, et al. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study. Ann Rheum Dis. 2021;80(10):1330–38. doi:10.1136/annrheumdis-2021-220647.
  • Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58(5):295–300. doi:10.1177/003591576505800503.
  • Escott S, Tarabishy AB, Davidorf FH. Multifocal choroiditis following simultaneous hepatitis A, typhoid, and yellow fever vaccination. Clin Ophthalmol (Auckland, NZ). 2013;7:363–65. doi:10.2147/OPTH.S37443.
  • Fraunfelder FW, Suhler EB, Fraunfelder FT. Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports. Cutan Ocul Toxicol. 2010;29(1):26–29. doi:10.3109/15569520903427717.
  • Testi I, Brandão-de-Resende C, Agrawal R, Pavesio C. Ocular inflammatory events following COVID-19 vaccination: a multinational case series. J Ophthalmic Inflamm Infect. 2022;12(1):4. doi:10.1186/s12348-021-00275-x.
  • Choudhary MM, Hajj-Ali RA, Lowder CY. Gender and ocular manifestations of connective tissue diseases and systemic vasculitides. J Ophthalmol. 2014;2014:403042. doi:10.1155/2014/403042.
  • Fairweather D, Frisancho-Kiss S, Rose NR. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol. 2008;173(3):600–09. doi:10.2353/ajpath.2008.071008.